Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Monlunabant

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Inversago Pharma · Phase 1 · Completed · Enrollment 73

NCT06542536

ArmPopulationDoseWeeksEstimandWeight change
Monlunabant dose 1Obesity or overweightn/rn/rn/rn/r
Monlunabant dose 2Obesity or overweightn/rn/rn/rn/r
Monlunabant dose 3Obesity or overweightn/rn/rn/rn/r
Placebo (monlunabant)Obesity or overweightn/rn/rn/rn/r